Editas Medicine (EDIT) Net Margin Growth (5y) (2020 - 2025)
Editas Medicine (EDIT) Net Margin Growth (5y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Editas Medicine |
262.77 Mn |
262.77 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-34,541.00 |
| Jun 30, 2025 |
-121,941.00 |
| Mar 31, 2025 |
-96,520.00 |
| Dec 31, 2024 |
15,915.00 |
| Sep 30, 2024 |
-10.10 Mn |
| Jun 30, 2024 |
-1.17 Mn |
| Mar 31, 2024 |
-404,500.00 |
| Dec 31, 2023 |
37,804.00 |
| Sep 30, 2023 |
-73,873.00 |
| Jun 30, 2023 |
-87,005.00 |
| Mar 31, 2023 |
30,616.00 |
| Dec 31, 2022 |
5,766.00 |
| Sep 30, 2022 |
-13.23 Mn |
| Jun 30, 2022 |
981.00 |
| Mar 31, 2022 |
381,708.00 |
| Dec 31, 2021 |
405,255.00 |
| Sep 30, 2021 |
155,406.00 |
| Jun 30, 2021 |
-1.40 Mn |
| Mar 31, 2021 |
133,699.00 |
| Dec 31, 2020 |
106,025.00 |
